Nexalin Technology Inc. (NXLIW)
0.19
-0.02 (-9.52%)
At close: Mar 13, 2025, 11:48 AM
-9.52% (1D)
| Bid | 0.22 |
| Market Cap | 27.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.36 |
| Volume | 7,609 |
| Avg. Volume (20D) | 18,522.751 |
| Open | 0.18 |
| Previous Close | 0.21 |
| Day's Range | 0.15 - 0.19 |
| 52-Week Range | 0.16 - 0.22 |
| Beta | 4.39 |
About NXLIW
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various m...
Industry Medical - Devices
Sector Healthcare
IPO Date n/a
Employees 6
Stock Exchange NASDAQ
Ticker Symbol NXLIW
Website https://www.nexalin.com